CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...